A Phase III, Multicenter Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Superficial Papillary Lesions in Patients With Bladder Cancer-Reference-Cited by-同舟云学术

A Phase III, Multicenter Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Superficial Papillary Lesions in Patients With Bladder Cancer

Published:2007-07 Issue:1 Volume:178 Page:62-67
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Grossman H. Barton¹,Gomella Leonard²,Fradet Yves³,Morales Alvaro⁴,Presti Joseph⁵,Ritenour Chad⁶,Nseyo Unyime⁷,Droller Michael J.⁸,

Affiliation:

1. University of Texas M. D. Anderson Cancer Center, Houston, Texas

2. Kimel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania

3. L’Hotel-Dieu de Québec, Centre Hospitalier Universitaire de Québec, Québec, Province de Québec, Canada

4. Kingston General Hospital, Kingston, Ontario, Canada

5. Stanford Cancer Center, Palo Alto, California

6. Emory Clinic, Atlanta, Georgia

7. McGuire Veterans Affairs Medical Center, Richmond, Virginia

8. Department of Urology, Mount Sinai Medical Center, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference14 articles.

1. Cancer of the Bladder 1990. National Institutes of Health Publication No. 90-722. Bethesda: National Cancer Institute.

2. SEER Cancer Statistics Review 1973–1994;Ries,1997

3. Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients;Herr;World J Urol,1997

4. Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions;Zaak;Cancer,2000

5. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer—a multicenter study;Jichlinski;J Urol,2003

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non–muscle-invasive Bladder Cancer. NEJM Evid 2022;1:EVIDoa2200092;European Urology;2024-02

2. Proteomics Profiling of Bladder Cancer Tissues from Early to Advanced Stages Reveals NNMT and GALK1 as Biomarkers for Early Detection and Prognosis of BCa;International Journal of Molecular Sciences;2023-10-06

3. A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients;BMC Medicine;2023-09-19

4. 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy;Bioengineering;2023-04-21

5. Economic Outcomes of Hexaminolevulinate Blue-Light Cystoscopy in Non-Muscle Invasive Bladder Cancer: A 5-Year, Medicare-Based Model;Bladder Cancer;2023-03-31